These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22476595

  • 21. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ, CREDO Investigators.
    Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
    [Abstract] [Full Text] [Related]

  • 22. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
    Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL, Køber L, Torp-Pedersen C, Gislason GH, Hansen ML.
    Circulation; 2012 Sep 04; 126(10):1185-93. PubMed ID: 22869839
    [Abstract] [Full Text] [Related]

  • 23. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L, Bueno H, Johansson S, García Rodríguez LA.
    Pharmacoepidemiol Drug Saf; 2012 May 04; 21(5):463-9. PubMed ID: 22298501
    [Abstract] [Full Text] [Related]

  • 24. Clopidogrel and proton pump inhibitors--where do we stand in 2012?
    Drepper MD, Spahr L, Frossard JL.
    World J Gastroenterol; 2012 May 14; 18(18):2161-71. PubMed ID: 22611308
    [Abstract] [Full Text] [Related]

  • 25. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M, Herszényi L, Tulassay Z.
    Digestion; 2010 May 14; 81(1):10-5. PubMed ID: 20029203
    [Abstract] [Full Text] [Related]

  • 26. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
    Liberopoulos EN, Elisaf MS, Tselepis AD, Archimandritis A, Kiskinis D, Cokkinos D, Mikhailidis DP.
    Platelets; 2006 Feb 14; 17(1):1-6. PubMed ID: 16308180
    [Abstract] [Full Text] [Related]

  • 27. Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Mizia-Stec K, Haberka M, Mizia M, Lasota B, Kunecki M, Gieszczyk K, Chmiel A, Najda J, Kyrcz-Krzemień S, Gąsior Z.
    Pharmacol Rep; 2012 Feb 14; 64(2):360-8. PubMed ID: 22661187
    [Abstract] [Full Text] [Related]

  • 28. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
    Ng FH, Tunggal P, Chu WM, Lam KF, Li A, Chan K, Lau YK, Kng C, Keung KK, Kwan A, Wong BC.
    Am J Gastroenterol; 2012 Mar 14; 107(3):389-96. PubMed ID: 22108447
    [Abstract] [Full Text] [Related]

  • 29. [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
    Yasu T, Ikee R, Miyasaka Y, Chubachi H, Saito S.
    Yakugaku Zasshi; 2010 Dec 14; 130(12):1743-50. PubMed ID: 21139402
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M.
    Eur J Intern Med; 2010 Dec 14; 21(6):484-9. PubMed ID: 21111931
    [Abstract] [Full Text] [Related]

  • 31. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
    CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.
    N Engl J Med; 2010 Sep 02; 363(10):930-42. PubMed ID: 20818903
    [Abstract] [Full Text] [Related]

  • 32. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH, Wong SY, Lam KF, Chang CM, Lau YK, Chu WM, Wong BC.
    Am J Gastroenterol; 2008 Apr 02; 103(4):865-71. PubMed ID: 18177451
    [Abstract] [Full Text] [Related]

  • 33. Gastrointestinal bleeding after percutaneous coronary intervention.
    Tanigawa T, Watanabe T, Nadatani Y, Otani K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T.
    Digestion; 2011 Apr 02; 83(3):153-60. PubMed ID: 21266809
    [Abstract] [Full Text] [Related]

  • 34. Anti-platelet therapy and managing ulcer risk.
    Chan FK.
    J Gastroenterol Hepatol; 2012 Feb 02; 27(2):195-9. PubMed ID: 22142030
    [Abstract] [Full Text] [Related]

  • 35. Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
    Furuta T.
    Intern Med; 2009 Feb 02; 48(21):1847-8. PubMed ID: 19881232
    [No Abstract] [Full Text] [Related]

  • 36. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
    Suzuki Y, Suzuki H, Umetsu R, Uranishi H, Abe J, Nishibata Y, Sekiya Y, Miyamura N, Hara H, Tsuchiya T, Kinosada Y, Nakamura M.
    Biol Pharm Bull; 2015 Feb 02; 38(5):680-6. PubMed ID: 25947914
    [Abstract] [Full Text] [Related]

  • 37. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM.
    Ann Intern Med; 2010 Mar 16; 152(6):337-45. PubMed ID: 20231564
    [Abstract] [Full Text] [Related]

  • 38. Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
    Gargiulo G, Costa F, Ariotti S, Biscaglia S, Campo G, Esposito G, Leonardi S, Vranckx P, Windecker S, Valgimigli M.
    Am Heart J; 2016 Apr 16; 174():95-102. PubMed ID: 26995375
    [Abstract] [Full Text] [Related]

  • 39. [Clinical impact of dual antiplatelet therapy on peptic ulcer disease].
    Ahn DG, Kim BJ, Kim JW, Kim JG.
    Korean J Gastroenterol; 2014 Aug 16; 64(2):81-6. PubMed ID: 25168049
    [Abstract] [Full Text] [Related]

  • 40. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI.
    J Gastroenterol Hepatol; 2012 Apr 16; 27(4):654-61. PubMed ID: 22283743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.